Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus cholinesterase inhibition to reduce neurologic decline in Alzheimer's - Butler_2021_Contemp.Clin.Trials__106488 |
| Author(s) : Butler T , Goldberg JD , Galvin JE , Maloney T , Ravdin L , Glodzik L , de Leon MJ , Hochman T , Bowen RL , Atwood CS |
| Ref : Contemp Clin Trials , :106488 , 2021 |
| Abstract : Butler_2021_Contemp.Clin.Trials__106488 |
| ESTHER : Butler_2021_Contemp.Clin.Trials__106488 |
| PubMedSearch : Butler_2021_Contemp.Clin.Trials__106488 |
| PubMedID: 34166841 |
| Title : A clinical study of lupron depot in the treatment of women with Alzheimer's disease: preservation of cognitive function in patients taking an acetylcholinesterase inhibitor and treated with high dose lupron over 48 weeks - Bowen_2015_J.Alzheimers.Dis_44_549 |
| Author(s) : Bowen RL , Perry G , Xiong C , Smith MA , Atwood CS |
| Ref : J Alzheimers Dis , 44 :549 , 2015 |
| Abstract : Bowen_2015_J.Alzheimers.Dis_44_549 |
| ESTHER : Bowen_2015_J.Alzheimers.Dis_44_549 |
| PubMedSearch : Bowen_2015_J.Alzheimers.Dis_44_549 |
| PubMedID: 25310993 |